This study demonstrates that PCV13 is immunogenic and safe in children previously vaccinated with PCV7. By eliciting high antibacterial immune responses to the additional serotypes, PCV13 provides protection against these serotypes, which are important causes of pneumococcal disease globally.
The evidence presented in the article strongly supports the notion that serotype replacement has occurred in invasive pneumococcal disease in most populations and is caused by the vaccine.
EDCC launched a tender to produce guidelines to assist Member States to implement invasive mosquito vector surveillance and improve coverage and harmonization of data collection within the EU.
Between 21 May and 5 December, 2011, 63 cases of Plasmodium vivax infection have been reported in Greece. The majority of cases (n=57) are reported from the area of Evrotas in Lakonia district, Peloponnese in southern Greece.
Since the 21 June, ECDC has published on its website weekly updates on spatial distribution of West Nile fever cases in the European Union and neighbouring countries.
The objective of this expert consultation was to guide, harmonize and enhance the surveillance and prevention of tick-borne diseases in EU Member States, with special emphasis on Lyme borreliosis and tick-borne encephalitis.
ECDC publishes weekly West Nile fever maps, based on information provided by the health authorities across Europe, with the objective to inform the national competent authorities about WNV affected areas.
According to the available epidemiological and entomological information, and the arriving winter season, the intensity of malaria transmission in Evrotas, Lakonia in Greece is very low.